ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

MXCN Maxcyte Inc

680,00
0,00 (0,00%)
Zuletzt aktualisiert: 02:00:00
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Maxcyte Inc MXCN London Ordinary Share
  Änderung Änderung % Aktuell Zeit
0,00 0,00% 680,00 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
680,00
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
07.5.202422:05GLOBEMaxCyte Reports First Quarter 2024 Financial Results and..
10.4.202414:05GLOBEMaxCyte to Report First Quarter 2024 Financial Results on..
02.4.202414:05GLOBEMaxCyte Signs Strategic Platform License with Be Biopharma..
12.3.202421:05UKREGMaxCyte Reports Fourth Quarter and Full Year 2023 Financial..
04.3.202422:05UKREGMaxCyte Initiates Full Year 2024 Guidance and Reaffirms 2023..
09.2.202414:05UKREGMaxCyte to Report Fourth Quarter and Full Year 2023..
30.1.202414:05UKREGMaxCyte and Wugen Sign Strategic Platform License to..
23.1.202414:05GLOBEMaxCyte Signs Strategic Platform License with Imugene to..
08.1.202422:05GLOBEMaxCyte Announces Preliminary Unaudited Fourth Quarter and..
03.1.202414:05GLOBEMaxCyte and Lion TCR form Partnership to Support Global..
02.1.202408:00GLOBEMaxCyte Confirms Appointment of Maher Masoud as President,..
11.12.202322:05GLOBEMaxCyte Announces CEO Transition and Updates Revenue..
16.11.202314:05GLOBEMaxCyte Joins the Alliance for mRNA Medicines (AMM) as a..
08.11.202322:05GLOBEMaxCyte Reports Third Quarter 2023 Financial Results and..
06.11.202322:05GLOBEMaxCyte to Participate in Two Upcoming Investor Conferences
04.10.202322:05GLOBEMaxCyte Announces Preliminary Third Quarter 2023 Revenue and..
06.9.202314:05GLOBEMaxCyte Appoints Ali Soleymannezhad as Executive Vice..
05.9.202314:05GLOBEMaxCyte to Participate in Baird Global Healthcare Conference
09.8.202322:05GLOBEMaxCyte Reports Second Quarter and Half-Year 2023 Financial..
01.8.202314:05GLOBEMaxCyte Signs Strategic Platform License with Prime Medicine..
13.7.202314:05GLOBEMaxCyte to Report Second Quarter 2023 Financial Results on..
10.7.202314:05GLOBEMaxCyte and Vittoria Biotherapeutics Sign Strategic Platform..
06.7.202314:05GLOBEMaxCyte Signs Strategic Platform License with Lyell..
01.6.202322:05GLOBEMaxCyte to Participate in Upcoming Investor Conferences

Kürzlich von Ihnen besucht

Delayed Upgrade Clock